Studies have shown that the occurrence and development of cancer are closely related to the accumulation of all kinds of “toxins” in the body. The “toxins” not only include external harmful substance like the heavy metal, but also mutated cells, excessive free radicals and metabolic wastes. Choosing an effective way to eliminate these toxins is one of the significant treatment for cancer. The application of chelation therapy in cancer marks the progress of such therapy. Chelation therapy is a crucial part of Non-Toxic Integrative Cancer Treatment. It plays an important role in modern malignant tumor treatment.
Chelation Therapy mainly applies Vitamin C, Vitamin B17 and chelating drugs for cancer treatment.
Vitamin C is essential to the body and it is a common vitamin. Modern research has proven that Vitamin C can damage and kill cancer cell in a selective manner at pharmacologic concentration.
Vitamin C does not harm normal cells and it is of vital importance in clinical application. This is the fundamental difference between Vitamin C and many chemotherapy drugs. Vitamin C can damage and kill malignant tumor cell selectively but has no negative effect on metabolism and organ function. Therefore, Vitamin C is available for several types of medium and advanced cancer patients. Vitamin C has strong potential in treating malignant tumor and its drug adaptability in patients is good. Vitamin C therapy has been used in treating malignant tumor for over 30 years and there is extensive foreign reports.
Vitamin B17 plays an important role in Non-Toxic Integrative Cancer Treatment for its special function against malignant tumor. In the 1950s, Dr. Krebs found Vitamin B17 and first applied it in malignant cancer treatment. The anti-cancer theory of Vitamin B17 put forward by Dr. Krebs consists of two parts. First, cyanide hydride can damage and kill cancer cells. Secondly, cyanide hydride conducts non-toxic metabolism in the body. Several studies both domestic and foreign have proven that applying Vitamin B17 to advanced cancer patients can relieve symptoms, extend their life expectancy and alleviate side effects of radiotherapy and chemotherapy.
Chelation and detoxification therapy is a treatment that applies NaFeEDTA through intravenous drip. NaFeEDTA is not metabolized by the body but it works as chelating agent and reaches the tissue and organs through blood circulation. This chelating agent chelates the metal that accumulate in the tissue and organs, including calcium, iron, copper, lead, aluminum, mercury, arsenic, cadmium, nickel. Then a non-toxic, stable and soluble compound is formed. This compound is excreted from the body through the kidneys, eliminating the accumulated toxic heavy metal, to achieve the goal of chelation and detoxification. The mechanism of chelation and detoxification therapy includes four aspects which are; chelating heavy metal, remedying calcium overload, preventing the premature aging of cells and eliminating free radicals. Since the 1970s, the famous American scientist Cameron and Professor Pauling, who was honored with Nobel Prize twice have first applied chelation and detoxification therapy with a high dose of Vitamin C in integrative cancer treatment and achieved excellent curative effect.
International Development
The synergistic effect of Vitamin C and Vitamin K3
In recent years, many medical scientists have studied that Vitamin C and Vitamin K3 have strong synergistic anti-cancer effects. Belgian medical scientists Taper and American oncologist Gilloteaux et al worked together to make a further study on this synergistic anti-cancer effect. It showed that the combination of Vitamin C and Vitamin K3 can boost the DNA enzymes in the cancer cells. The anti-cancer pharmacological properties of Vitamin K3 are related to its chemical structure naphthoquinone. Naphthoquinone produces hydrogen sulfide and amine in intracellular metabolism. This has a direct cytotoxicity and destroys cancer cells. So far, there is no report about treating cancer patients with Vitamin K3 alone. However, there are several positive reports of clinical trial in regards to the combination of Vitamin C and Vitamin K3 in treating cancer patients.
Ukrain
It has been proven that Ukrain can inhibit and dissolve 60 types of cancer cells (brain, ovary,colon, kidney cancer, small and non-small cell lung cancer, sarcoma, leukemia and lymphoma). Also, Ukrain can inhibit the cell cycle in pro-phase and meta-phase through single tubulin and induce apoptosis in pancreatic cancer cell (Jurkat, THP-1, MIA PaCa2, BxPC3 and AxPC1). Ukrain selectively induces apoptosis in cancer cells but has no effect on normal cells. In the past 20 years, Ukrain has been used as an adjuvant drug in cancer treatment and its anti-tumor mechanism remains uncertain. Besides enhancing immune function, Ukrain injection can inhibit the growth of cancer cells during gap 2 phase or mitotic period, and it can induce apoptosis in cancer cells. The mechanism of inducing apoptosis in cancer cells may be inducing mitochondrial membrane depolarization and boosting caspase. The inducing function of Ukrain comes from the extraction of alkaloids from the celandine.
